BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
MOLECULAR TARGETUniProt: P80192

MAP3K9

mitogen-activated protein kinase kinase kinase 9

28 compounds · BiohacksAI corpus v20260307-01

28
compounds
Compounds
28
Gene Symbol
MAP3K9
NCBI Gene
4293

Looking for compounds that interact with MAP3K9?

View all 28 compounds →
About MAP3K9

MAP3K9 (mitogen-activated protein kinase kinase kinase 9) is a biological target studied in biomedical research. The BiohacksAI corpus identifies 28 compounds with documented interactions with this target, based on BindingDB assay data and PubMed literature.

View MAP3K9 on UniProt →
Compounds Targeting MAP3K9 (28)
1
Alvocidib
4.52
confidence
2
Foretinib
4.34
confidence
3
Tozasertib
4.33
confidence
4
Bosutinib
4.08
confidence
5
Midostaurin
3.85
confidence
6
Brigatinib
3.81
confidence
7
Pazopanib
3.69
confidence
8
Neratinib
3.66
confidence
9
Nintedanib
3.61
confidence
10
Tae 684
3.43
confidence
11
Fedratinib
3.40
confidence
12
Dovitinib
3.09
confidence
13
Jnj 7706621
3.09
confidence
14
Lestaurtinib
3.04
confidence
15
Ruboxistaurin
2.94
confidence
16
R 406
2.83
confidence
17
Staurosporinone
2.77
confidence
18
Apitolisib
2.71
confidence
19
Kw 2449
2.64
confidence
20
Atuveciclib
2.56
confidence
21
Defactinib
2.48
confidence
22
Gsk 461364
2.40
confidence
23
Berzosertib
2.30
confidence
24
Su 014813
2.20
confidence
25
Rebastinib
2.20
confidence
26
Cep 1347
2.08
confidence
27
Cerdulatinib
1.95
confidence
298
studies
0.69
confidence
Top 28 compounds by confidence score. Derived from BindingDB assay data.
Data Source
Corpusv20260307-01
SourceBindingDB · ChEMBL · PubMed

All data is computationally derived from published research. Not medical advice. Independent validation required.